Sanofi

Sanofi Extends $18.5 Billion Genzyme Offer To Jan 21

Antitrust Probe in the EU Pharma Sector

Ralph Whitworth:Right Sanofi Price 'Lots Higher'

Sanofi Says CVR Interesting, No Comment on Genzyme

Campath Clause OK For Genzyme In Sanofi Bid

Genzyme Meets First Consent Decree Deadline

New Deal Structure for Genzyme?

Astra Tech: AstraZeneca Confirms Considering Spin-Off

Sanofi Asks Genzyme To Let Investors Decide On Bid

Sanofi Expands Consumer Health With China Buy

Sanofi, Merck Begin Vet Drugs Sell-Off

EU To Seek Details Of Deals Delaying Generic Drugs

Sanofi Gets OK From U.S. Authorites for Genzyme Bid

Sanofi CEO Says Nothing Has Changed On Genzyme Bid

Sanofi Denies It Dangled Higher Bid Before Genzyme

Sanofi to Cut 25% of U.S. Pharma Operations

Genzyme Says Sanofi Proposed $69-$80/Share Price Range

Sanofi Seen Raising Hostile Bid, Eventually

Sanofi Launches Hostile $18.5 Billion Bid For Genzyme

Sanofi Repeats Genzyme Offer Amid Talk Of New Bid

Novo's new Insulin Less Variable than Sanofi Rival

Sanofi Board Heavyweights may Be Key to Genzyme Deal

Sanofi CEO Sees Reasonable Chance of Genzyme Deal

Genzyme Confirms 1,000 Job Cuts over 15 Months

Sanofi Sticks to $69 per Share Genzyme Offer

Sanofi has $10 Billion in Loans for Genzyme Bid

Sanofi CEO Meets Genzyme Holders, Mulls Next Move

Sanofi-Aventis Ready to Raise Bid if Genzyme Talks

Genzyme's Hand Strengthening vs Sanofi

Total Hopes to Sell Lindsey Refinery by Year-end

Genzyme Rejects Sanofi Offer, Long Battle Looms

Genzyme Rejects Sanofi-Aventis' $18.5 billion Offer

Sanofi Makes $69 per Share Genzyme Offer

Sanofi Top Two Shareholders Seen Wary on Genzyme Bid

Sanofi Won't Go Above $70 per Share for Genzyme

31 more articles

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Predictive Simulation in Pharma Production

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Article

The State of the US Specialty Chemicals Industry

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.